These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35990945)

  • 1. Associations of body mass index with mortality in heart failure with preserved ejection fraction patients with ischemic versus non-ischemic etiology.
    Zeng S; Cai X; Zheng Y; Liu X; Ye M
    Front Cardiovasc Med; 2022; 9():966745. PubMed ID: 35990945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "Obesity Paradox" in Patients With HFpEF With or Without Comorbid Atrial Fibrillation.
    Guo L; Liu X; Yu P; Zhu W
    Front Cardiovasc Med; 2021; 8():743327. PubMed ID: 35087875
    [No Abstract]   [Full Text] [Related]  

  • 3. Associations of BMI with mortality in HFpEF patients with concomitant diabetes with insulin versus non-insulin treatment.
    Ye M; Choy M; Liu X; Huang P; Wu Y; Dong Y; Zhu W; Liu C
    Diabetes Res Clin Pract; 2022 Mar; 185():109805. PubMed ID: 35219761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial.
    Dong B; Yao Y; Xue R; Liang W; He J; Wei F; Dong Y; He X; Liu C
    BMC Med; 2022 Nov; 20(1):423. PubMed ID: 36324141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction.
    Mandviwala TM; Basra SS; Khalid U; Pickett JK; Przybylowicz R; Shah T; Nambi V; Virani SS; Deswal A
    Int J Obes (Lond); 2020 Jul; 44(7):1561-1567. PubMed ID: 32483205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
    Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
    JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index and clinical outcomes in patients with heart failure with preserved ejection fraction mediated by diastolic blood pressure status?
    Hu Y; Gu Z; Xu M; He W; Wu L; Xu Z; Guo L
    Heliyon; 2023 Jun; 9(6):e16515. PubMed ID: 37274719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Body Mass Index and Abdominal Obesity with Incidence of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction.
    Huang X; Liu X; Jiang Y; Cao Z; Wu M; Chen Z; Sun R; Yu P; Ma J; Zhu W; Chen Y; Wu G; Zhang Y; Wang J
    Curr Med Chem; 2023 Jun; ():. PubMed ID: 37282653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction.
    Li Y; Yu Y; Wu Y; Liang W; Dong B; Xue R; Dong Y; Zhu W; Huang P
    Front Cardiovasc Med; 2021; 8():689591. PubMed ID: 34195237
    [No Abstract]   [Full Text] [Related]  

  • 10. Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?
    Prausmüller S; Weidenhammer A; Heitzinger G; Spinka G; Goliasch G; Arfsten H; Abdel Mawgoud R; Gabler C; Strunk G; Hengstenberg C; Hülsmann M; Bartko PE; Pavo N
    Eur J Prev Cardiol; 2023 Sep; 30(12):1247-1254. PubMed ID: 37210596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose-response meta-analysis.
    Zhang J; Begley A; Jackson R; Harrison M; Pellicori P; Clark AL; Cleland JGF
    Clin Res Cardiol; 2019 Feb; 108(2):119-132. PubMed ID: 29951802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of obesity with heart failure outcomes in 11 Asian regions: A cohort study.
    Chandramouli C; Tay WT; Bamadhaj NS; Tromp J; Teng TK; Yap JJL; MacDonald MR; Hung CL; Streng K; Naik A; Wander GS; Sawhney J; Ling LH; Richards AM; Anand I; Voors AA; Lam CSP;
    PLoS Med; 2019 Sep; 16(9):e1002916. PubMed ID: 31550265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obesity paradox in heart failure: is etiology a key factor?
    Zamora E; Lupón J; de Antonio M; Urrutia A; Coll R; Díez C; Altimir S; Bayés-Genís A
    Int J Cardiol; 2013 Jul; 166(3):601-5. PubMed ID: 22204855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction.
    Huang P; Guo Z; Liang W; Wu Y; Zhao J; He X; Zhu W; Liu C; Dong Y; Yu Y; Dong B
    Front Cardiovasc Med; 2021; 8():681726. PubMed ID: 34150872
    [No Abstract]   [Full Text] [Related]  

  • 15. Obesity Paradox in Heart Failure Revisited: Etiology as Effect Modifier.
    Huang L; Zhao X; Liang L; Tian P; Chen Y; Zhai M; Huang Y; Zhou Q; Zhang Y; Zhang J
    Am J Cardiol; 2023 Nov; 207():294-301. PubMed ID: 37769574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Heart Failure Overweight/Obesity Survival Paradox: The Missing Sex Link.
    Vest AR; Wu Y; Hachamovitch R; Young JB; Cho L
    JACC Heart Fail; 2015 Nov; 3(11):917-26. PubMed ID: 26454846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of body mass index and prognosis in patients with HFpEF: A dose-response meta-analysis.
    Li S; Zheng Y; Huang Y; He W; Liu X; Zhu W
    Int J Cardiol; 2022 Aug; 361():40-46. PubMed ID: 35568057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.
    Padwal R; McAlister FA; McMurray JJ; Cowie MR; Rich M; Pocock S; Swedberg K; Maggioni A; Gamble G; Ariti C; Earle N; Whalley G; Poppe KK; Doughty RN; Bayes-Genis A;
    Int J Obes (Lond); 2014 Aug; 38(8):1110-4. PubMed ID: 24173404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
    Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
    JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry).
    Jin X; Cao J; Zhou J; Wang Y; Han X; Song Y; Fan Y; Chen Z; Xu D; Yang X; Dong W; Li L; Chen L; Zhong Q; Fu M; Hu K; Zhou J; Ge J;
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100415. PubMed ID: 31508483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.